Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 2Sarcoma, Kaposi 2Sarcoma 2Melanoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Kidney Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 5Filgrastim 4Zidovudine 3Vincristine 3Etoposide 3Valganciclovir 2Thalidomide 2Rituximab 2Mitoxantrone 2Interferon alpha-2 2Cyclophosphamide 2Bleomycin 2ziconotide 1vesnarinone 1tocilizumab 1tin etiopurpurin 1interferon gamma-1b 1human papillomavirus vaccine, L1 type 16, 18 1Vinblastine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Prednisone 1Paclitaxel 1Nivolumab 1Mitoguazone 1Methotrexate 1Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Acquired Immunodeficiency Syndrome × Semaxinib × Clear all
NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
30 enrolled
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡